Abstract:Coronavirus Disease (COVID-19), that begun from Wuhan, China and spread rapidly and to worldwide. Since, cancer patients are more susceptible to different types of infection with have higher risk of severe symptoms of COVID-19 than patients without cancer. The objective of this study is determine mortality rate in cancer patients with COVID-19 through used systematic reviews and Meta-Analyses by searched COVID-19, cancer patients, mortality rate patients with cancer, mortality rate patients with COVID-19. In order to collect the data, valid databases (i.e., MEDLINE, ISI Web of Science, PubMed, EMBASE, Scopus, Google Scholar, and Science Direct) were systematically searched. Five hundred and forty-five (545) studies were identified on valid databases (electronic literature search) were screened by title, abstract and full-text articles were identified for eligibility. Seven study data of patients with severe COVID-19 reported higher mortality among patients with hematologic versus those with non-hematologic cancers (79.9% v 55.6%), and no difference in mortality among cancer + COVID-19 patients with comorbidity compared with those without any comorbidity (33.1% v 33.6%). In conclusion; patients with cancer and COVID-19 had a significantly higher risk of mortality outcomes then patients with COVID-19 without cancer. Doctors and other medical staff must be tolerated take care with cancer patients in the COVID-19 visitors.

Mortality rate in cancer patients with COVID-19: meta-analysis data